These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 31111775)

  • 1. Use of multiple performance and symptom validity measures: Determining the optimal per test cutoff for determination of invalidity, analysis of skew, and inter-test correlations in valid and invalid performance groups.
    Larrabee GJ; Rohling ML; Meyers JE
    Clin Neuropsychol; 2019 Nov; 33(8):1354-1372. PubMed ID: 31111775
    [No Abstract]   [Full Text] [Related]  

  • 2. Lowered cutoffs to reduce false positives on the Word Memory Test.
    Rohling ML; Demakis GJ; Langhinrichsen-Rohling J
    J Clin Exp Neuropsychol; 2024 Feb; 46(1):67-79. PubMed ID: 38362939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Word Memory Test genuine memory impairment profile discriminates genuine memory impairment from invalid performance in a mixed clinical sample with cognitive impairment.
    Alverson WA; O'Rourke JJF; Soble JR
    Clin Neuropsychol; 2019 Nov; 33(8):1420-1435. PubMed ID: 31002017
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of the Word Memory Test and the Test of Memory Malingering in detecting invalid performance in neuropsychological testing.
    Bhowmick C; Hirst R; Green P
    Appl Neuropsychol Adult; 2021; 28(4):486-496. PubMed ID: 31519112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the classification accuracy of multiple performance validity tests in a mixed clinical sample.
    Messerly J; Soble JR; Webber TA; Alverson WA; Fullen C; Kraemer LD; Marceaux JC
    Appl Neuropsychol Adult; 2021; 28(6):727-736. PubMed ID: 31835915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychometric implications of failure on one performance validity test: a cross-validation study to inform criterion group definition.
    Rhoads T; Neale AC; Resch ZJ; Cohen CD; Keezer RD; Cerny BM; Jennette KJ; Ovsiew GP; Soble JR
    J Clin Exp Neuropsychol; 2021 Jul; 43(5):437-448. PubMed ID: 34233580
    [No Abstract]   [Full Text] [Related]  

  • 7. Examination of the relationship between symptom and performance validity measures across referral subtypes.
    Boress K; Gaasedelen O; Kim JH; Basso MR; Whiteside DM
    J Clin Exp Neuropsychol; 2024 Mar; 46(2):162-171. PubMed ID: 37791494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance and symptom validity assessment in attention deficit/hyperactivity disorder: Base rates of invalidity, concordance, and relative impact on cognitive performance.
    Ovsiew GP; Cerny BM; Boer AB; Petry LG; Resch ZJ; Durkin NM; Soble JR
    Clin Neuropsychol; 2023 Oct; 37(7):1498-1515. PubMed ID: 36594201
    [No Abstract]   [Full Text] [Related]  

  • 9. False-positive rates associated with the use of multiple performance and symptom validity tests.
    Larrabee GJ
    Arch Clin Neuropsychol; 2014 Jun; 29(4):364-73. PubMed ID: 24769887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Comparison of Performance Validity Measures in Predicting MMPI-2 Lie Scale Results.
    Richey LN; Doninger NA
    Clin Neuropsychol; 2020 Feb; 34(2):353-367. PubMed ID: 31340718
    [No Abstract]   [Full Text] [Related]  

  • 11. Results From Three Performance Validity Tests (PVTs) in Adults With Intellectual Deficits.
    Green P; Flaro L
    Appl Neuropsychol Adult; 2015; 22(4):293-303. PubMed ID: 25496190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detecting coached neuropsychological dysfunction: a simulation experiment regarding mild traumatic brain injury.
    Lau L; Basso MR; Estevis E; Miller A; Whiteside DM; Combs D; Arentsen TJ
    Clin Neuropsychol; 2017 Nov; 31(8):1412-1431. PubMed ID: 28415909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive impairment does not cause invalid performance: analyzing performance patterns among cognitively unimpaired, impaired, and noncredible participants across six performance validity tests.
    Critchfield E; Soble JR; Marceaux JC; Bain KM; Chase Bailey K; Webber TA; Alex Alverson W; Messerly J; Andrés González D; O'Rourke JJF
    Clin Neuropsychol; 2019 Aug; 33(6):1083-1101. PubMed ID: 30475095
    [No Abstract]   [Full Text] [Related]  

  • 14. Performance validity in undergraduate research participants: a comparison of failure rates across tests and cutoffs.
    An KY; Kaploun K; Erdodi LA; Abeare CA
    Clin Neuropsychol; 2017 Jan; 31(1):193-206. PubMed ID: 27687709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimizing false positive error with multiple performance validity tests: response to Bilder, Sugar, and Hellemann (2014 this issue).
    Larrabee GJ
    Clin Neuropsychol; 2014; 28(8):1230-42. PubMed ID: 25491180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research methods in performance validity testing studies: Criterion grouping approach impacts study outcomes.
    Schroeder RW; Martin PK; Heinrichs RJ; Baade LE
    Clin Neuropsychol; 2019 Apr; 33(3):466-477. PubMed ID: 29884112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validity of informant report interpretations: Role of examinee performance and symptom invalidity.
    Webber TA; Sullivan-Baca E; Modiano YA; Taiwo Z; Grabyan JM
    Psychol Assess; 2022 Feb; 34(2):125-138. PubMed ID: 34647761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance on the Test of Memory Malingering is predicted by the number of errors on its first 10 items on an inpatient epilepsy monitoring unit.
    Grabyan JM; Collins RL; Alverson WA; Chen DK
    Clin Neuropsychol; 2018 Apr; 32(3):468-478. PubMed ID: 28826306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of race and other demographic factors on the false positive rates of five embedded Performance Validity Tests (PVTs) in a Veteran sample.
    Denning JH; Horner MD
    J Clin Exp Neuropsychol; 2024 Feb; 46(1):25-35. PubMed ID: 38353039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive Analysis of MMPI-2-RF Symptom Validity Scales and Performance Validity Test Relationships in a Diverse Mixed Neuropsychiatric Setting.
    De Boer AB; Phillips MS; Barwegen KC; Obolsky MA; Rauch AA; Pesanti SD; Tse PKY; Ovsiew GP; Jennette KJ; Resch ZJ; Soble JR
    Psychol Inj Law; 2023; 16(1):61-72. PubMed ID: 36348958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.